Industry Research Reports

Home > Reports > Chemical & Material > Copovidone (PVP-VA)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Copovidone (PVP-VA)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Chemical & Material

Published Date: 2026-07-14

Pages: 140 Pages

Report ld: 6922949

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Copovidone (PVP-VA) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

Copovidone, also known as PVP-VA, is a copolymer used as a binder, film-former, and solubilizer in pharmaceutical formulations.

The market for copovidone is driven by its applications in solid oral dosage forms, providing enhanced drug release and solubility. The increasing demand for pharmaceutical excipients and advanced drug formulations further boosts the adoption of copovidone.

This report provides a comprehensive view of the global market for Copovidone (PVP-VA), covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Copovidone (PVP-VA) market size, estimations, and forecasts are presented in terms of sales volume (MT) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Copovidone (PVP-VA).

MARKET SEGMENTATION

By Company

Ashland
BASF
Boai Nky Pharmaceuticals
Star-Tech & JRS Specialty Products
Hangzhou Motto Science & Technology
Shanghai Yuking Water Soluble Material
JH Nanhang Life Sciences
Jiaozuo Zhongwei Special Products Pharmaceutical
Huzhou Sunflower Pharmaceutical
Huangshan Bonsun Pharmaceuticals
Jiaozuo Meida

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Medical Grade
Food Grade
Industrial Grade

Segment by Application

Adhesive
Film Former
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Copovidone (PVP-VA) manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Copovidone (PVP-VA) sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Copovidone (PVP-VA) sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Copovidone (PVP-VA) Product Introduction

1.2 Global Copovidone (PVP-VA) Market Size Forecast

1.2.1 Global Copovidone (PVP-VA) Sales Value (2021–2032)

1.2.2 Global Copovidone (PVP-VA) Sales Volume (2021–2032)

1.2.3 Global Copovidone (PVP-VA) Sales Price (2021–2032)

1.3 Copovidone (PVP-VA) Market Trends & Drivers

1.3.1 Copovidone (PVP-VA) Industry Trends

1.3.2 Copovidone (PVP-VA) Market Drivers & Opportunities

1.3.3 Copovidone (PVP-VA) Market Challenges

1.3.4 Copovidone (PVP-VA) Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Copovidone (PVP-VA) Players Revenue Ranking (2025)

2.2 Global Copovidone (PVP-VA) Revenue by Company (2021–2026)

2.3 Global Copovidone (PVP-VA) Sales Volume Ranking of Players (2025)

2.4 Global Copovidone (PVP-VA) Sales Volume by Company (2021–2026)

2.5 Global Copovidone (PVP-VA) Average Price by Company (2021–2026)

2.6 Key Manufacturers Copovidone (PVP-VA) Manufacturing Base and Headquarters

2.7 Key Manufacturers Copovidone (PVP-VA) Product Offerings

2.8 Key Manufacturers Start of Mass Production of Copovidone (PVP-VA)

2.9 Copovidone (PVP-VA) Market Competitive Analysis

2.9.1 Copovidone (PVP-VA) Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Copovidone (PVP-VA) Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Copovidone (PVP-VA) revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Copovidone (PVP-VA) Market Classification

3.1 Introduction by Type

3.1.1 Medical Grade

3.1.2 Food Grade

3.1.3 Industrial Grade

3.1.4 Global Copovidone (PVP-VA) Sales Value by Type

3.1.4.1 Global Copovidone (PVP-VA) Sales Value by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Copovidone (PVP-VA) Sales Value, by Type (2021–2032)

3.1.4.3 Global Copovidone (PVP-VA) Sales Value, by Type (%), 2021–2032

3.1.5 Global Copovidone (PVP-VA) Sales Volume by Type

3.1.5.1 Global Copovidone (PVP-VA) Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.5.2 Global Copovidone (PVP-VA) Sales Volume, by Type (2021–2032)

3.1.5.3 Global Copovidone (PVP-VA) Sales Volume, by Type (%), 2021–2032

3.1.6 Global Copovidone (PVP-VA) Average Price by Type (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Adhesive

4.1.2 Film Former

4.1.3 Other

4.2 Global Copovidone (PVP-VA) Sales Value by Application

4.2.1 Global Copovidone (PVP-VA) Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Copovidone (PVP-VA) Sales Value, by Application (2021–2032)

4.2.3 Global Copovidone (PVP-VA) Sales Value, by Application (%), 2021–2032

4.3 Global Copovidone (PVP-VA) Sales Volume by Application

4.3.1 Global Copovidone (PVP-VA) Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Copovidone (PVP-VA) Sales Volume, by Application (2021–2032)

4.3.3 Global Copovidone (PVP-VA) Sales Volume, by Application (%), 2021–2032

4.4 Global Copovidone (PVP-VA) Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Copovidone (PVP-VA) Sales Value by Region

5.1.1 Global Copovidone (PVP-VA) Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Copovidone (PVP-VA) Sales Value by Region (2021–2026)

5.1.3 Global Copovidone (PVP-VA) Sales Value by Region (2027–2032)

5.1.4 Global Copovidone (PVP-VA) Sales Value by Region (%), 2021–2032

5.2 Global Copovidone (PVP-VA) Sales Volume by Region

5.2.1 Global Copovidone (PVP-VA) Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Copovidone (PVP-VA) Sales Volume by Region (2021–2026)

5.2.3 Global Copovidone (PVP-VA) Sales Volume by Region (2027–2032)

5.2.4 Global Copovidone (PVP-VA) Sales Volume by Region (%), 2021–2032

5.3 Global Copovidone (PVP-VA) Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Copovidone (PVP-VA) Sales Value, 2021–2032

5.4.2 North America Copovidone (PVP-VA) Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Copovidone (PVP-VA) Sales Value, 2021–2032

5.5.2 Europe Copovidone (PVP-VA) Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Copovidone (PVP-VA) Sales Value, 2021–2032

5.6.2 Asia Pacific Copovidone (PVP-VA) Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Copovidone (PVP-VA) Sales Value, 2021–2032

5.7.2 South America Copovidone (PVP-VA) Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Copovidone (PVP-VA) Sales Value, 2021–2032

5.8.2 Middle East & Africa Copovidone (PVP-VA) Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Copovidone (PVP-VA) Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Copovidone (PVP-VA) Sales Value and Sales Volume

6.2.1 Key Countries/Regions Copovidone (PVP-VA) Sales Value, 2021–2032

6.2.2 Key Countries/Regions Copovidone (PVP-VA) Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Copovidone (PVP-VA) Sales Value, 2021–2032

6.3.2 United States Copovidone (PVP-VA) Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Copovidone (PVP-VA) Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Copovidone (PVP-VA) Sales Value, 2021–2032

6.4.2 Europe Copovidone (PVP-VA) Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Copovidone (PVP-VA) Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Copovidone (PVP-VA) Sales Value, 2021–2032

6.5.2 China Copovidone (PVP-VA) Sales Value by Type (%), 2025 vs 2032

6.5.3 China Copovidone (PVP-VA) Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Copovidone (PVP-VA) Sales Value, 2021–2032

6.6.2 Japan Copovidone (PVP-VA) Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Copovidone (PVP-VA) Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Copovidone (PVP-VA) Sales Value, 2021–2032

6.7.2 South Korea Copovidone (PVP-VA) Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Copovidone (PVP-VA) Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Copovidone (PVP-VA) Sales Value, 2021–2032

6.8.2 Southeast Asia Copovidone (PVP-VA) Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Copovidone (PVP-VA) Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Copovidone (PVP-VA) Sales Value, 2021–2032

6.9.2 India Copovidone (PVP-VA) Sales Value by Type (%), 2025 vs 2032

6.9.3 India Copovidone (PVP-VA) Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Ashland

7.1.1 Ashland Company Information

7.1.2 Ashland Introduction and Business Overview

7.1.3 Ashland Copovidone (PVP-VA) Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 Ashland Copovidone (PVP-VA) Product Offerings

7.1.5 Ashland Recent Developments

7.2 BASF

7.2.1 BASF Company Information

7.2.2 BASF Introduction and Business Overview

7.2.3 BASF Copovidone (PVP-VA) Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 BASF Copovidone (PVP-VA) Product Offerings

7.2.5 BASF Recent Developments

7.3 Boai Nky Pharmaceuticals

7.3.1 Boai Nky Pharmaceuticals Company Information

7.3.2 Boai Nky Pharmaceuticals Introduction and Business Overview

7.3.3 Boai Nky Pharmaceuticals Copovidone (PVP-VA) Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 Boai Nky Pharmaceuticals Copovidone (PVP-VA) Product Offerings

7.3.5 Boai Nky Pharmaceuticals Recent Developments

7.4 Star-Tech & JRS Specialty Products

7.4.1 Star-Tech & JRS Specialty Products Company Information

7.4.2 Star-Tech & JRS Specialty Products Introduction and Business Overview

7.4.3 Star-Tech & JRS Specialty Products Copovidone (PVP-VA) Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 Star-Tech & JRS Specialty Products Copovidone (PVP-VA) Product Offerings

7.4.5 Star-Tech & JRS Specialty Products Recent Developments

7.5 Hangzhou Motto Science & Technology

7.5.1 Hangzhou Motto Science & Technology Company Information

7.5.2 Hangzhou Motto Science & Technology Introduction and Business Overview

7.5.3 Hangzhou Motto Science & Technology Copovidone (PVP-VA) Sales, Revenue, Price and Gross Margin (2021–2026)

7.5.4 Hangzhou Motto Science & Technology Copovidone (PVP-VA) Product Offerings

7.5.5 Hangzhou Motto Science & Technology Recent Developments

7.6 Shanghai Yuking Water Soluble Material

7.6.1 Shanghai Yuking Water Soluble Material Company Information

7.6.2 Shanghai Yuking Water Soluble Material Introduction and Business Overview

7.6.3 Shanghai Yuking Water Soluble Material Copovidone (PVP-VA) Sales, Revenue, Price and Gross Margin (2021–2026)

7.6.4 Shanghai Yuking Water Soluble Material Copovidone (PVP-VA) Product Offerings

7.6.5 Shanghai Yuking Water Soluble Material Recent Developments

7.7 JH Nanhang Life Sciences

7.7.1 JH Nanhang Life Sciences Company Information

7.7.2 JH Nanhang Life Sciences Introduction and Business Overview

7.7.3 JH Nanhang Life Sciences Copovidone (PVP-VA) Sales, Revenue, Price and Gross Margin (2021–2026)

7.7.4 JH Nanhang Life Sciences Copovidone (PVP-VA) Product Offerings

7.7.5 JH Nanhang Life Sciences Recent Developments

7.8 Jiaozuo Zhongwei Special Products Pharmaceutical

7.8.1 Jiaozuo Zhongwei Special Products Pharmaceutical Company Information

7.8.2 Jiaozuo Zhongwei Special Products Pharmaceutical Introduction and Business Overview

7.8.3 Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone (PVP-VA) Sales, Revenue, Price and Gross Margin (2021–2026)

7.8.4 Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone (PVP-VA) Product Offerings

7.8.5 Jiaozuo Zhongwei Special Products Pharmaceutical Recent Developments

7.9 Huzhou Sunflower Pharmaceutical

7.9.1 Huzhou Sunflower Pharmaceutical Company Information

7.9.2 Huzhou Sunflower Pharmaceutical Introduction and Business Overview

7.9.3 Huzhou Sunflower Pharmaceutical Copovidone (PVP-VA) Sales, Revenue, Price and Gross Margin (2021–2026)

7.9.4 Huzhou Sunflower Pharmaceutical Copovidone (PVP-VA) Product Offerings

7.9.5 Huzhou Sunflower Pharmaceutical Recent Developments

7.10 Huangshan Bonsun Pharmaceuticals

7.10.1 Huangshan Bonsun Pharmaceuticals Company Information

7.10.2 Huangshan Bonsun Pharmaceuticals Introduction and Business Overview

7.10.3 Huangshan Bonsun Pharmaceuticals Copovidone (PVP-VA) Sales, Revenue, Price and Gross Margin (2021–2026)

7.10.4 Huangshan Bonsun Pharmaceuticals Copovidone (PVP-VA) Product Offerings

7.10.5 Huangshan Bonsun Pharmaceuticals Recent Developments

7.11 Jiaozuo Meida

7.11.1 Jiaozuo Meida Company Information

7.11.2 Jiaozuo Meida Introduction and Business Overview

7.11.3 Jiaozuo Meida Copovidone (PVP-VA) Sales, Revenue, Price and Gross Margin (2021–2026)

7.11.4 Jiaozuo Meida Copovidone (PVP-VA) Product Offerings

7.11.5 Jiaozuo Meida Recent Developments

8 Industry Chain Analysis

8.1 Copovidone (PVP-VA) Industrial Chain

8.2 Copovidone (PVP-VA) Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Copovidone (PVP-VA) Sales Model

8.5.2 Sales Channels

8.5.3 Copovidone (PVP-VA) Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Copovidone (PVP-VA) Market Trends

Table 2. Copovidone (PVP-VA) Market Drivers & Opportunities

Table 3. Copovidone (PVP-VA) Market Challenges

Table 4. Copovidone (PVP-VA) Market Restraints

Table 5. Global Copovidone (PVP-VA) Revenue by Company (US$ Million), 2021–2026

Table 6. Global Copovidone (PVP-VA) Revenue Market Share by Company (2021–2026)

Table 7. Global Copovidone (PVP-VA) Sales Volume by Company (MT), 2021–2026

Table 8. Global Copovidone (PVP-VA) Sales Volume Market Share by Company (2021–2026)

Table 9. Global Market Copovidone (PVP-VA) Price by Company (USD/Kg), 2021–2026

Table 10. Key Manufacturers Copovidone (PVP-VA) Manufacturing Base and Headquarters

Table 11. Key Manufacturers Copovidone (PVP-VA) Product Type

Table 12. Key Manufacturers Start of Mass Production of Copovidone (PVP-VA)

Table 13. Global Copovidone (PVP-VA) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Copovidone (PVP-VA) revenue, 2025

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Copovidone (PVP-VA) Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Copovidone (PVP-VA) Sales Value by Type (US$ Million), 2021–2026

Table 18. Global Copovidone (PVP-VA) Sales Value by Type (US$ Million), 2027–2032

Table 19. Global Copovidone (PVP-VA) Sales Market Share in Value by Type (2021–2026)

Table 20. Global Copovidone (PVP-VA) Sales Market Share in Value by Type (2027–2032)

Table 21. Global Copovidone (PVP-VA) Sales Volume by Type: 2021 vs 2025 vs 2032 (MT)

Table 22. Global Copovidone (PVP-VA) Sales Volume by Type (MT), 2021–2026

Table 23. Global Copovidone (PVP-VA) Sales Volume by Type (MT), 2027–2032

Table 24. Global Copovidone (PVP-VA) Sales Market Share in Volume by Type (2021–2026)

Table 25. Global Copovidone (PVP-VA) Sales Market Share in Volume by Type (2027–2032)

Table 26. Global Copovidone (PVP-VA) Price by Type (USD/Kg), 2021–2026

Table 27. Global Copovidone (PVP-VA) Price by Type (USD/Kg), 2027–2032

Table 28. Global Copovidone (PVP-VA) Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Copovidone (PVP-VA) Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Copovidone (PVP-VA) Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Copovidone (PVP-VA) Sales Market Share in Value by Application (2021–2026)

Table 32. Global Copovidone (PVP-VA) Sales Market Share in Value by Application (2027–2032)

Table 33. Global Copovidone (PVP-VA) Sales Volume by Application: 2021 vs 2025 vs 2032 (MT)

Table 34. Global Copovidone (PVP-VA) Sales Volume by Application (MT), 2021–2026

Table 35. Global Copovidone (PVP-VA) Sales Volume by Application (MT), 2027–2032

Table 36. Global Copovidone (PVP-VA) Sales Market Share in Volume by Application (2021–2026)

Table 37. Global Copovidone (PVP-VA) Sales Market Share in Volume by Application (2027–2032)

Table 38. Global Copovidone (PVP-VA) Price by Application (USD/Kg), 2021–2026

Table 39. Global Copovidone (PVP-VA) Price by Application (USD/Kg), 2027–2032

Table 40. Global Copovidone (PVP-VA) Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 41. Global Copovidone (PVP-VA) Sales Value by Region (US$ Million), 2021–2026

Table 42. Global Copovidone (PVP-VA) Sales Value by Region (US$ Million), 2027–2032

Table 43. Global Copovidone (PVP-VA) Sales Value by Region (%), 2021–2026

Table 44. Global Copovidone (PVP-VA) Sales Value by Region (%), 2027–2032

Table 45. Global Copovidone (PVP-VA) Sales Volume by Region (MT): 2021 vs 2025 vs 2032

Table 46. Global Copovidone (PVP-VA) Sales Volume by Region (MT), 2021–2026

Table 47. Global Copovidone (PVP-VA) Sales Volume by Region (MT), 2027–2032

Table 48. Global Copovidone (PVP-VA) Sales Volume by Region (%), 2021–2026

Table 49. Global Copovidone (PVP-VA) Sales Volume by Region (%), 2027–2032

Table 50. Global Copovidone (PVP-VA) Average Price by Region (USD/Kg), 2021–2026

Table 51. Global Copovidone (PVP-VA) Average Price by Region (USD/Kg), 2027–2032

Table 52. Key Countries/Regions Copovidone (PVP-VA) Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 53. Key Countries/Regions Copovidone (PVP-VA) Sales Value, (US$ Million), 2021–2026

Table 54. Key Countries/Regions Copovidone (PVP-VA) Sales Value, (US$ Million), 2027–2032

Table 55. Key Countries/Regions Copovidone (PVP-VA) Sales Volume, (MT), 2021–2026

Table 56. Key Countries/Regions Copovidone (PVP-VA) Sales Volume, (MT), 2027–2032

Table 57. Ashland Company Information

Table 58. Ashland Introduction and Business Overview

Table 59. Ashland Copovidone (PVP-VA) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)

Table 60. Ashland Copovidone (PVP-VA) Product Offerings

Table 61. Ashland Recent Developments

Table 62. BASF Company Information

Table 63. BASF Introduction and Business Overview

Table 64. BASF Copovidone (PVP-VA) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)

Table 65. BASF Copovidone (PVP-VA) Product Offerings

Table 66. BASF Recent Developments

Table 67. Boai Nky Pharmaceuticals Company Information

Table 68. Boai Nky Pharmaceuticals Introduction and Business Overview

Table 69. Boai Nky Pharmaceuticals Copovidone (PVP-VA) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)

Table 70. Boai Nky Pharmaceuticals Copovidone (PVP-VA) Product Offerings

Table 71. Boai Nky Pharmaceuticals Recent Developments

Table 72. Star-Tech & JRS Specialty Products Company Information

Table 73. Star-Tech & JRS Specialty Products Introduction and Business Overview

Table 74. Star-Tech & JRS Specialty Products Copovidone (PVP-VA) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)

Table 75. Star-Tech & JRS Specialty Products Copovidone (PVP-VA) Product Offerings

Table 76. Star-Tech & JRS Specialty Products Recent Developments

Table 77. Hangzhou Motto Science & Technology Company Information

Table 78. Hangzhou Motto Science & Technology Introduction and Business Overview

Table 79. Hangzhou Motto Science & Technology Copovidone (PVP-VA) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)

Table 80. Hangzhou Motto Science & Technology Copovidone (PVP-VA) Product Offerings

Table 81. Hangzhou Motto Science & Technology Recent Developments

Table 82. Shanghai Yuking Water Soluble Material Company Information

Table 83. Shanghai Yuking Water Soluble Material Introduction and Business Overview

Table 84. Shanghai Yuking Water Soluble Material Copovidone (PVP-VA) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)

Table 85. Shanghai Yuking Water Soluble Material Copovidone (PVP-VA) Product Offerings

Table 86. Shanghai Yuking Water Soluble Material Recent Developments

Table 87. JH Nanhang Life Sciences Company Information

Table 88. JH Nanhang Life Sciences Introduction and Business Overview

Table 89. JH Nanhang Life Sciences Copovidone (PVP-VA) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)

Table 90. JH Nanhang Life Sciences Copovidone (PVP-VA) Product Offerings

Table 91. JH Nanhang Life Sciences Recent Developments

Table 92. Jiaozuo Zhongwei Special Products Pharmaceutical Company Information

Table 93. Jiaozuo Zhongwei Special Products Pharmaceutical Introduction and Business Overview

Table 94. Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone (PVP-VA) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)

Table 95. Jiaozuo Zhongwei Special Products Pharmaceutical Copovidone (PVP-VA) Product Offerings

Table 96. Jiaozuo Zhongwei Special Products Pharmaceutical Recent Developments

Table 97. Huzhou Sunflower Pharmaceutical Company Information

Table 98. Huzhou Sunflower Pharmaceutical Introduction and Business Overview

Table 99. Huzhou Sunflower Pharmaceutical Copovidone (PVP-VA) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)

Table 100. Huzhou Sunflower Pharmaceutical Copovidone (PVP-VA) Product Offerings

Table 101. Huzhou Sunflower Pharmaceutical Recent Developments

Table 102. Huangshan Bonsun Pharmaceuticals Company Information

Table 103. Huangshan Bonsun Pharmaceuticals Introduction and Business Overview

Table 104. Huangshan Bonsun Pharmaceuticals Copovidone (PVP-VA) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)

Table 105. Huangshan Bonsun Pharmaceuticals Copovidone (PVP-VA) Product Offerings

Table 106. Huangshan Bonsun Pharmaceuticals Recent Developments

Table 107. Jiaozuo Meida Company Information

Table 108. Jiaozuo Meida Introduction and Business Overview

Table 109. Jiaozuo Meida Copovidone (PVP-VA) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021–2026)

Table 110. Jiaozuo Meida Copovidone (PVP-VA) Product Offerings

Table 111. Jiaozuo Meida Recent Developments

Table 112. Key Raw Materials Lists

Table 113. Key Suppliers of Raw Materials Lists

Table 114. Copovidone (PVP-VA) Downstream Customers

Table 115. Copovidone (PVP-VA) Distributors List

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Copovidone (PVP-VA) Product Picture

Figure 2. Global Copovidone (PVP-VA) Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Copovidone (PVP-VA) Sales Value (US$ Million), 2021–2032

Figure 4. Global Copovidone (PVP-VA) Sales Volume (MT), 2021–2032

Figure 5. Global Copovidone (PVP-VA) Sales Price (USD/Kg), 2021–2032

Figure 6. Copovidone (PVP-VA) Report Years Considered

Figure 7. Global Copovidone (PVP-VA) Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Copovidone (PVP-VA) Sales Volume Ranking of Players (MT), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Copovidone (PVP-VA) Revenue in 2025

Figure 10. Copovidone (PVP-VA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. Medical Grade Picture

Figure 12. Food Grade Picture

Figure 13. Industrial Grade Picture

Figure 14. Global Copovidone (PVP-VA) Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Copovidone (PVP-VA) Sales Value Market Share by Type, 2025 & 2032

Figure 16. Global Copovidone (PVP-VA) Sales Volume by Type (MT), 2021 vs 2025 vs 2032

Figure 17. Global Copovidone (PVP-VA) Sales Volume Market Share by Type, 2025 & 2032

Figure 18. Global Copovidone (PVP-VA) Price by Type (USD/Kg), 2021–2032

Figure 19. Product Picture of Adhesive

Figure 20. Product Picture of Film Former

Figure 21. Product Picture of Other

Figure 22. Global Copovidone (PVP-VA) Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Copovidone (PVP-VA) Sales Value Market Share by Application, 2025 & 2032

Figure 24. Global Copovidone (PVP-VA) Sales Volume by Application (MT), 2021 vs 2025 vs 2032

Figure 25. Global Copovidone (PVP-VA) Sales Volume Market Share by Application, 2025 & 2032

Figure 26. Global Copovidone (PVP-VA) Price by Application (USD/Kg), 2021–2032

Figure 27. North America Copovidone (PVP-VA) Sales Value (US$ Million), 2021–2032

Figure 28. North America Copovidone (PVP-VA) Sales Value by Country (%), 2025 vs 2032

Figure 29. Europe Copovidone (PVP-VA) Sales Value (US$ Million), 2021–2032

Figure 30. Europe Copovidone (PVP-VA) Sales Value by Country (%), 2025 vs 2032

Figure 31. Asia Pacific Copovidone (PVP-VA) Sales Value (US$ Million), 2021–2032

Figure 32. Asia Pacific Copovidone (PVP-VA) Sales Value by Region (%), 2025 vs 2032

Figure 33. South America Copovidone (PVP-VA) Sales Value (US$ Million), 2021–2032

Figure 34. South America Copovidone (PVP-VA) Sales Value by Country (%), 2025 vs 2032

Figure 35. Middle East & Africa Copovidone (PVP-VA) Sales Value (US$ Million), 2021–2032

Figure 36. Middle East & Africa Copovidone (PVP-VA) Sales Value by Country (%), 2025 vs 2032

Figure 37. Key Countries/Regions Copovidone (PVP-VA) Sales Value (%), 2021–2032

Figure 38. Key Countries/Regions Copovidone (PVP-VA) Sales Volume (%), 2021–2032

Figure 39. United States Copovidone (PVP-VA) Sales Value (US$ Million), 2021–2032

Figure 40. United States Copovidone (PVP-VA) Sales Value by Type (%), 2025 vs 2032

Figure 41. United States Copovidone (PVP-VA) Sales Value by Application (%), 2025 vs 2032

Figure 42. Europe Copovidone (PVP-VA) Sales Value (US$ Million), 2021–2032

Figure 43. Europe Copovidone (PVP-VA) Sales Value by Type (%), 2025 vs 2032

Figure 44. Europe Copovidone (PVP-VA) Sales Value by Application (%), 2025 vs 2032

Figure 45. China Copovidone (PVP-VA) Sales Value (US$ Million), 2021–2032

Figure 46. China Copovidone (PVP-VA) Sales Value by Type (%), 2025 vs 2032

Figure 47. China Copovidone (PVP-VA) Sales Value by Application (%), 2025 vs 2032

Figure 48. Japan Copovidone (PVP-VA) Sales Value (US$ Million), 2021–2032

Figure 49. Japan Copovidone (PVP-VA) Sales Value by Type (%), 2025 vs 2032

Figure 50. Japan Copovidone (PVP-VA) Sales Value by Application (%), 2025 vs 2032

Figure 51. South Korea Copovidone (PVP-VA) Sales Value (US$ Million), 2021–2032

Figure 52. South Korea Copovidone (PVP-VA) Sales Value by Type (%), 2025 vs 2032

Figure 53. South Korea Copovidone (PVP-VA) Sales Value by Application (%), 2025 vs 2032

Figure 54. Southeast Asia Copovidone (PVP-VA) Sales Value (US$ Million), 2021–2032

Figure 55. Southeast Asia Copovidone (PVP-VA) Sales Value by Type (%), 2025 vs 2032

Figure 56. Southeast Asia Copovidone (PVP-VA) Sales Value by Application (%), 2025 vs 2032

Figure 57. India Copovidone (PVP-VA) Sales Value (US$ Million), 2021–2032

Figure 58. India Copovidone (PVP-VA) Sales Value by Type (%), 2025 vs 2032

Figure 59. India Copovidone (PVP-VA) Sales Value by Application (%), 2025 vs 2032

Figure 60. Copovidone (PVP-VA) Industrial Chain

Figure 61. Copovidone (PVP-VA) Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Copovidone (PVP-VA) market? zhanKai

The top companies in the global Copovidone (PVP-VA) market are Ashland、BASF、Boai Nky Pharmaceuticals.

Related Reports

Global Copovidone (PVP-VA) Market Research Report 2026
The global Copovidone (PVP-VA) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 141
USD 2900.00
(Single User License)
Global Copovidone (PVP-VA) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Copovidone (PVP-VA) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 170
USD 4900.00
(Single User License)
Global Copovidone (PVP-VA) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Copovidone (PVP-VA) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 100
USD 4250.00
(Single User License)
Copovidone (PVP-VA)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Copovidone (PVP-VA) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 113
USD 3950.00
(Single User License)
Global Copovidone (PVP-VA) Market Research Report 2025
The global market for Copovidone (PVP-VA) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 99
USD 2900.00
(Single User License)

Global Copovidone (PVP-VA) Market Research Report 2026
The global Copovidone (PVP-VA) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 141
USD 2900.00 (Single User License)
Global Copovidone (PVP-VA) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Copovidone (PVP-VA) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 170
USD 4900.00 (Single User License)
Global Copovidone (PVP-VA) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Copovidone (PVP-VA) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 100
USD 4250.00 (Single User License)
Copovidone (PVP-VA)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Copovidone (PVP-VA) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 113
USD 3950.00 (Single User License)
Global Copovidone (PVP-VA) Market Research Report 2025
The global market for Copovidone (PVP-VA) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 99
USD 2900.00 (Single User License)